Filter
4484
Filtered Results: 4484
Text search:
drug
strategy
Featured
Recommendations
389
New Publications
1253
Language
Document type
No document type
2714
Studies & Reports
734
Guidelines
526
Manuals
188
Strategic & Response Plan
169
Fact sheets
60
Training Material
50
Situation Updates
20
Infographics
13
Resource Platforms
6
Brochures
2
Dashboards/Maps
1
App
1
Countries / Regions
India
225
Global
164
Kenya
152
South Africa
115
Uganda
113
Ethiopia
106
Western and Central Europe
100
Nigeria
94
Nepal
86
Liberia
80
Zambia
78
Tanzania
77
Sierra Leone
76
Malawi
74
Myanmar / Burma
72
Latin America and the Carribbean
70
Bangladesh
63
Africa
62
Ghana
58
Rwanda
53
Eastern Europe
49
Namibia
44
Ukraine
42
Philippines
41
Indonesia
40
Asia
39
Zimbabwe
36
Cambodia
36
South–East Asia Region
34
Lesotho
31
Botswana
25
Russia
24
Syria
22
Congo, Democratic Republic of
20
Colombia
18
Mozambique
18
Senegal
17
Eswatini/ Swaziland
16
Burkina Faso
15
Brazil
15
East and Southern Africa
14
West and Central Africa
13
South Sudan
13
Middle East and North Africa
12
Eastern Europe and Central Asia
12
Cameroon
11
Albania
11
Tajikistan
10
Thailand
10
Venezuela
10
Pakistan
10
Guinea
9
USA
9
Haiti
9
Sudan
9
Georgia
9
Germany
8
Peru
7
Western Pacific Region
7
Vietnam
7
Benin
6
Laos
6
Afghanistan
6
Argentina
6
China
5
North America
5
Sri Lanka
5
Iraq
5
North Macedonia
4
Mexico
4
Turkey
4
Iran
4
Jordan
4
Lebanon
4
Moldova
4
Yemen
4
Central African Republic
4
Timor Leste/ East Timor
3
El Salvador
3
Armenia
3
Paraguay
3
Jamaica
3
Bolivia
3
Bhutan
3
Somalia
3
Estonia
2
Kyrgyzstan
2
Uzbekistan
2
Morocco
2
Hungary
2
Saudi Arabia
2
United Kingdom
2
Portugal
2
Spain
2
Southern Africa
2
Côte d’Ivoire / Ivory Coast
2
Papua New Guinea
2
Honduras
2
Libya
2
Madagascar
2
North Korea
1
Switzerland
1
Serbia
1
Gambia
1
Kazakhstan
1
Chile
1
Canada
1
Fiji
1
Austria
1
Mongolia
1
Qatar
1
Bulgaria
1
Lithuania
1
Ireland
1
Gabon
1
Uruguay
1
Turkmenistan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Nicaragua
1
Romania
1
Greece
1
Palestine
1
Poland
1
Mali
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1801
Clinical Guidelines
366
Public Health
236
Women & Child Health
149
Key Resources
130
Capacity Building
49
Pharmacy & Technologies
44
Annual Report MEDBOX
1
Toolboxes
HIV
555
TB
458
Mental Health
338
AMR
239
NTDs
205
COVID-19
168
Pharmacy
109
NCDs
99
Rapid Response
81
Caregiver
74
Ebola & Marburg
64
Planetary Health
63
Malaria
63
Conflict
52
Global Health Education
48
Disability
47
Refugee
45
Health Financing Toolbox
45
Polio
22
Natural Hazards
17
Cholera
15
Specific Hazards
14
Zika
10
Social Ethics
9
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO, which considers Pharmacovigilance, an essential component of public health programs. Its intention was...
The use of Delamanid and Bedaquiline for Children with Drug-Resistant Tuberculosis.
Antimicrobial agents like antibiotics are essential to treat some human and animal diseases. Microbes, such as bacteria, can develop resistance to antimicrobials meaning that a drug such as an antibiotic is no longer effective in treating the infection. The development of resistance is caused by the...
Nepal has only recently started its journey on the path to an integrated response to the challenge of antimicrobial resistance (AMR). Despite this, it is notable that the Nepal Health Sector Strategy Plan (HSSP)-2 mentions growing antibiotic resistanceas a public health challenge.
The Democratic Republic of Timor-Leste has the highest TB incidence rate in the South East Asian Region - 498 per 100,000, which is the seventh highest in the world. In Timor-Leste TB is the eighth most common cause of death.
The salient observations are as follows:
In 2018, 487 (12.5%) of the...
Barbados currently has a rudimentary framework and capacity to address the issue of antimicrobial resistance. There however needs to be coordination of efforts and improvement in areas where gaps have been identified.Actions required include improved antibiotic stewardship in healthcare settings, pr...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a disease or reduction of its effectiveness in improving the clinical signs of a disease. Antimicrobial ...
BMC Infectious Diseases (2019) 19:832
Intestinal schistosomiasis is highly endemic in Tanzania and mass drug administration (MDA) using
praziquantel is the mainstay of the control program. However, the MDA program covers only school aged children
and does not include neither adult individuals nor...
The Infection Prevention and Control (IPC) Legal Framework comes before the Specialized Technical Committee on Health and Drug Control for adoption and endorsement. The IPC Legal Framework is designed to guide Member States in the review and strengthening of laws and policies that support IPC at bot...
This revision covers the main non-communicable diseases in Mozambique as well as the National Strategic Plan's aim to create a positive environment to minimize or eliminate the exposure to risk factors and guarantee access to care.
Tuberculosis treatment failure results in increased risk of morbidity, drug resistance, transmission and mortality. There are few data about tuberculosis treatment outcomes in Burkina Faso. The current study investigated the factors associated with tuberculosis treatment failure in the central east ...
UNICEF Annual Report 2017 - Burkina Faso
- Healthcare policy for children
- Food insecurity
- Community health strategy
- National child protection system
etc.
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
Annex 1: Measuring progress towards targets
Annex 2: Modelling the impact of the 90-(90)-90 strategy
Annex 3: Investment packages by country setting
Annex 4: Country strategies
Annex 5: Strategic frameworks for research and development for new tools
Annex 6 : Estimating the cost of the 90-(90)-...
Due to the heterogeneous distribution of malaria transmission and its determinants, subnational tailoring (SNT) provides an analytical framework to facilitate the targeting of each population with appropriate intervention packages for maximum impact to inform national strategic planning and prioriti...
Estimating the size of key affected populations (KAP) provides important data for planning and implementing an effective response to the HIV epidemic. In the Philippines, these KAP include males who have sex with males (MSM), female sex workers (FSW), and injecting drug users (IDU). Given the diffic...
The main objective of these guidelines is to provide guidance on up-to-date, uniform, evidence-informed practices for suspecting, diagnosing and managing various forms of extra-pulmonary tuberculosis (EPTB) at all levels of healthcare delivery. They can then contribute to the National Programme to i...
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, base...
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.
This manual for developing national action plans to address antimicrobial resistance has been developed at the request of the World Health Assembly to assist countries in the initial phase of developing new, or refining existing national action plans in line with the
strategic objectives of the Glo...
